Hennion & Walsh Asset Management, Inc. Ironwood Pharmaceuticals Inc Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 187,773 shares of IRWD stock, worth $281,659. This represents 0.04% of its overall portfolio holdings.
Number of Shares
187,773
Previous 170,811
9.93%
Holding current value
$281,659
Previous $702,000
18.38%
% of portfolio
0.04%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding IRWD
# of Institutions
245Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$34.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$29.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$24.6 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$17.6 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$14.2 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $230M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...